Claudio Bucolo

University of Catania — Italy

Medicine · Health Sciences

56h-index10.1kcitations305works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(66), Glaucoma and retinal disorders(48), Ocular Surface and Contact Lens(40), Receptor Mechanisms and Signaling(35), Advanced Drug Delivery Systems(22)

Publications305 total

Retinal alterations resemble brain pathology in a rat model of Parkinson’s disease induced by intranigral infusion of α-synuclein oligomers
Cell Death Discovery·2025Open Access
Safety profile of lutein-based blue dyes and surgical lights
Frontiers in Pharmacology·2025Open Access
Safety and effectiveness of vital dyes for intraocular surgery
Progress in Retinal and Eye Research·2025
Editorial overview: Advanced therapies and new targets in ocular diseases
Current Opinion in Pharmacology·2025
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment
Cell Death and Disease·2025· 3 citedOpen Access
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy
British Journal of Pharmacology·2025· 3 citedOpen Access
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate
Frontiers in Pharmacology·2025· 3 citedOpen Access
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity
European Journal of Pharmacology·2025· 3 citedOpen Access
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Retinal Protection of New Nutraceutical Formulation
Pharmaceutics·2025· 4 citedOpen Access
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells
Neuropharmacology·2025· 1 citedOpen Access
From Preformulative Design to <i>in Vivo</i> Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> Studies
Molecular Pharmaceutics·2024· 4 cited
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach
Pharmaceuticals·2024· 2 citedOpen Access
Therapeutic innovations for geographic atrophy: A promising horizon
Current Opinion in Pharmacology·2024· 7 citedOpen Access
Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathy
Experimental Eye Research·2024· 10 citedOpen Access
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy
Frontiers in Pharmacology·2024· 8 citedOpen Access
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study
Frontiers in Pharmacology·2024Open Access
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
Current Oncology·2024· 14 citedOpen Access
Integrating network pharmacology: The next-generation approach in ocular drug discovery
Current Opinion in Pharmacology·2024· 26 citedOpen Access
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?
International Journal of Molecular Sciences·2023· 11 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Filippo Drago(34), Salvatore Salomone(17), Gian Marco Leggio(12), Chiara Bianca Maria Platania(12), Giovanni Puglisi(10), Rosario Pignatello(9), Filippo Caraci(8), Adriana Maltese(5), Giovanni Luca Romano(5), Giovanni Giurdanella(5), Michele Reibaldi(4), Annamaria Fidilio(4), Rosa Maisto(3), Maria Consiglia Trotta(3), Michele D’Amico(3), Velia D’Agata(3), Claudia G. Fresta(3), Margherita Grasso(3), Giuseppe Caruso(3), Chiara M. Eandi(3)